{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:52:51Z","timestamp":1767135171582,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd012284","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000}}],"reference-count":71,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012284.pub2","type":"journal-article","created":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T10:25:05Z","timestamp":1505730305000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Growth hormone therapy for people with thalassaemia"],"prefix":"10.1002","author":[{"given":"Chin Fang","family":"Ngim","sequence":"first","affiliation":[{"name":"Monash University Malaysia; Jeffrey Cheah School of Medicine and Health Sciences; Johor Bahru Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nai Ming","family":"Lai","sequence":"additional","affiliation":[{"name":"Taylor's University; School of Medicine; Subang Jaya Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet YH","family":"Hong","sequence":"additional","affiliation":[{"name":"Putrajaya Hospital; Department of Paediatrics; Precinct 7 Putrajaya Putrajaya Malaysia 62250"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shir Ley","family":"Tan","sequence":"additional","affiliation":[{"name":"Calvary North Adelaide Hospital; HPS Pharmacies; Adelaide South Australia Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amutha","family":"Ramadas","sequence":"additional","affiliation":[{"name":"Monash University Malaysia; Jeffrey Cheah School of Medicine and Health Sciences; Johor Bahru Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Premala","family":"Muthukumarasamy","sequence":"additional","affiliation":[{"name":"University of Malaya Medical Center; Department of Paediatrics; Jalan Universiti Kuala Lumpur Kuala Lumpur Malaysia 519000"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meow-Keong","family":"Thong","sequence":"additional","affiliation":[{"name":"University of Malaya Medical Center; Department of Paediatrics; Jalan Universiti Kuala Lumpur Kuala Lumpur Malaysia 519000"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,9,18]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD012284.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1442-200x.1999.01139.x","article-title":"Recombinant human growth hormone treatment in children with thalassemia major","volume":"41","author":"Arcasoy","year":"1999","journal-title":"Pediatrics International"},{"issue":"6","key":"10.1002\/14651858.CD012284.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/tropej\/fmn043","article-title":"Assessment of puberty in relation to L-carnitine and hormonal replacement therapy in beta-thalassemic patients","volume":"54","author":"Beshlawy","year":"2008","journal-title":"Journal of Tropical Pediatrics"},{"issue":"102(Supplement","key":"10.1002\/14651858.CD012284.pub2-BIB0003|cit3","first-page":"507","article-title":"Growth and normal puberty","volume":"1","author":"V","year":"1998","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/09723757.2003.11885858","article-title":"Growth retardation in thalassemia major patients","volume":"3","author":"Anita","year":"2003","journal-title":"International Journal of Human Genetics"},{"issue":"7","key":"10.1002\/14651858.CD012284.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00277-012-1412-7","article-title":"Serum ferritin levels and endocrinopathy in medically treated patients with beta thalassemia major","volume":"91","author":"Belhoul","year":"2012","journal-title":"Annals of Hematology"},{"issue":"1","key":"10.1002\/14651858.CD012284.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1210\/jc.2009-0178","article-title":"Long term safety of recombinant human growth hormone in children","volume":"95","author":"Bell","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD012284.pub2-BIB0007|cit7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010429.pub2","article-title":"Treatment for osteoporosis in people with \u00df-thalassaemia","author":"Bhardwaj","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0008|cit8","first-page":"1327-36","article-title":"Growth hormone deficiency and peak bone mass","volume":"13 Suppl 6","author":"Bouillon","year":"2000","journal-title":"Journal of Pediatric Endocrinology & Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD012284.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/1097-0258(20010215)20:3<391::AID-SIM800>3.0.CO;2-Z","article-title":"Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size","volume":"20","author":"Campbell","year":"2001","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0010|cit10","first-page":"148","volume-title":"Guidelines for the management of transfusion dependent thalassaemia (TDT)","author":"Cappelini","year":"2014"},{"issue":"2","key":"10.1002\/14651858.CD012284.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1210\/jc.2011-1995","article-title":"Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study","volume":"97","author":"Carel","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD012284.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF03347204","article-title":"Final height in short polytransfused thalassemia major patients treated with recombinant growth hormone","volume":"28","author":"Cavallo","year":"2005","journal-title":"Journal of Endocrinological Investigation"},{"issue":"9","key":"10.1002\/14651858.CD012284.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/BF01953984","article-title":"Evaluation of growth hormone in thalassaemic boys with failed puberty: spontaneous versus provocative test","volume":"152","author":"Chatterjee","year":"1993","journal-title":"European Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD012284.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"63-86","DOI":"10.1210\/edrv-16-1-63","article-title":"Clinical aspects of growth hormone deficiency in adults","volume":"16","author":"Boer","year":"1995","journal-title":"Endocrine Reviews"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0015|cit15","first-page":"72","article-title":"Growth and Puberty and Its Management in Thalassaemia","volume":"58 Suppl 1","author":"De","year":"2002","journal-title":"Hormone Research"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0016|cit16","first-page":"249","article-title":"Prevalence of endocrine complications and short stature in patients with thalassemia major: A multicenter study by Thalassemia International Federation (TIF)","volume":"2 Suppl 2","author":"Sanctis","year":"2004","journal-title":"Pediatric Endocrinology Reviews"},{"issue":"1","key":"10.1002\/14651858.CD012284.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/2230-8210.107808","article-title":"Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guidelines","volume":"17","author":"Sanctis","year":"2013","journal-title":"Indian Journal of Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0018|cit18","unstructured":"Deeks JJ Higgins JPT Altman DG editor(s) on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD012284.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF03346551","article-title":"Growth and endocrine function in thalassemia major in childhood and adolescence","volume":"33","author":"Delvecchio","year":"2010","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1750-1172-5-11","article-title":"Beta-thalassemia","volume":"5","author":"Galanello","year":"2010","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000341151","article-title":"Quality of Life in Children and Adolescents with Growth Hormone Deficiency: Association with Growth Hormone Treatment","volume":"78","author":"Geisler","year":"2012","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"10.1002\/14651858.CD012284.pub2-BIB0022|cit22","first-page":"250","article-title":"Using L-arabinose for production of human growth hormone in Escherichia coli, studying the processing of gIII: hGH precursor","volume":"2","author":"Ghasemi","year":"2004","journal-title":"Iranian Journal of Biotechnology"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-5-13","article-title":"Alpha-thalassaemia","volume":"5","author":"Harteveld","year":"2010","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"7414","key":"10.1002\/14651858.CD012284.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0025|cit25","unstructured":"Higgins JPT Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0026|cit26","unstructured":"Higgins JPT Deeks JJ editor(s) Chapter 7: Selecing studies and collecting data. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0027|cit27","unstructured":"Higgins JPT Altman DG Sterne JAC editor(s) on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0028|cit28","unstructured":"Higgins JPT Deeks JJ Altman DG editor(s) on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0029|cit29","unstructured":"Higgins JPT Deeks JJ Altman DG editor(s) on behalf of the Cochrane Statistical Methods Group Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0030|cit30","first-page":"133","article-title":"The molecular pathology of the thalassaemias","volume-title":"The Thalassaemia Syndrome","author":"Higgs","year":"2008"},{"issue":"1","key":"10.1002\/14651858.CD012284.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1210\/jcem-70-1-207","article-title":"Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites","volume":"70","author":"J\u00f8rgensen","year":"1990","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD012284.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.59566\/IJBS.2006.2236","article-title":"Endocrine function in thalassemia intermedia","volume":"2","author":"Karamifar","year":"2006","journal-title":"International Journal of Biomedical Science: IJBS"},{"issue":"6","key":"10.1002\/14651858.CD012284.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF02029352","article-title":"Circadian growth hormone secretion in short multitransfused prepubertal children with thalassaemia major","volume":"154","author":"Katzos","year":"1995","journal-title":"European Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD012284.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1515\/JPEM.2000.13.2.163","article-title":"Growth hormone treatment in short children with beta-thalassemia major","volume":"13","author":"Katzos","year":"2000","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD012284.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000183781","article-title":"Coping and satisfaction with growth hormone treatment among short-stature children","volume":"40","author":"Leiberman","year":"1993","journal-title":"Hormone Research in Paediatrics"},{"issue":"4","key":"10.1002\/14651858.CD012284.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2265.1995.tb02643.x","article-title":"Growth hormone treatment of short Chinese children with beta-thalassaemia major without GH deficiency","volume":"42","author":"Low","year":"1995","journal-title":"Clinical Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD012284.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2265.1998.00470.x","article-title":"Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with \u03b2-thalassaemia major and the effect of GH treatment","volume":"48","author":"Low","year":"1998","journal-title":"Clinical Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD012284.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF02760702","article-title":"Growth of children with beta-thalassemia major","volume":"72","author":"Low","year":"2005","journal-title":"Indian Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD012284.pub2-BIB0039|cit39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012284.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ajh.22247","article-title":"Pituitary iron and volume predict hypogonadism in transfusional iron overload","volume":"87","author":"Noetzli","year":"2012","journal-title":"American Journal of Hematology"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1136\/bmj.e228","article-title":"Diagnosis and management of thalassaemia","volume":"344","author":"Peters","year":"2012","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD012284.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.beem.2015.04.009","article-title":"Hormone replacement therapy in children: The use of growth hormone and IGF-I","volume":"29","author":"Pfaffle","year":"2015","journal-title":"Best Practice & Research. Clinical Endocrinology and Metabolism"},{"issue":"9","key":"10.1002\/14651858.CD012284.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1212\/WNL.0000000000000737","article-title":"Growth hormone treatment for childhood short stature and risk of stroke in early adulthood","volume":"83","author":"Poidvin","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD012284.pub2-BIB0044|cit44","first-page":"452","article-title":"A 5-year prospective study on growth hormone (GH)-deficient children treated with GH before the age of 3 years","volume":"82","author":"Rappaport","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0045|cit45","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"7","key":"10.1002\/14651858.CD012284.pub2-BIB0046|cit46","first-page":"681","article-title":"Optimization of production of recombinant human growth hormone in Escherichia coli","volume":"17","author":"Rezaei","year":"2012","journal-title":"Journal of Research in Medical Sciences"},{"issue":"8710","key":"10.1002\/14651858.CD012284.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Rosen","year":"1990","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD012284.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s004310050711","article-title":"Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion","volume":"156","author":"Roth","year":"1997","journal-title":"European Journal of Pediatrics"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1185\/03007995.2011.613922","article-title":"An observational study to validate the Satisfaction Measure of the Injection of Growth Hormone Therapy (SMIGHTy) questionnaire","volume":"27","author":"Rubin","year":"2011","journal-title":"Current Medical Research and Opinion"},{"issue":"5","key":"10.1002\/14651858.CD012284.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1210\/jcem.86.5.7439","article-title":"The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study","volume":"86","author":"Saggese","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD012284.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"E213-7","DOI":"10.1210\/jc.2011-2882","article-title":"Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study","volume":"97","author":"S\u00e4vendahl","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD012284.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-2265.2007.02965.x","article-title":"Growth hormone deficiency (GHD) in adult thalassaemic patients","volume":"67","author":"Scacchi","year":"2007","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0053|cit53","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH on behalf of the Cochrane Applicabiliy and Recommendations Methods Group and the Cochrane Statitical Methods Group Chapter 11: Presenting results and \u2018Summary of findings\u2019 tables. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0054|cit54","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"8-9","key":"10.1002\/14651858.CD012284.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1651-2227.1990.tb11556.x","article-title":"Neurosecretory dysfunction of growth hormone secretion in thalassemia major","volume":"79","author":"Shehadeh","year":"1990","journal-title":"Acta Paediatrica Scandinavia"},{"issue":"5","key":"10.1002\/14651858.CD012284.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/tropej\/42.5.291","article-title":"Insulin and glucagon responses to provocation with glucose and arginine in prepubertal children with thalassemia major before and after long-term blood transfusion","volume":"42","author":"Soliman","year":"1996","journal-title":"Journal of Tropical Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD012284.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"541-8","DOI":"10.1016\/S0026-0495(98)90237-2","article-title":"Bone mineral density in prepubertal children with beta-thalassemia: Correlation with growth and hormonal data","volume":"47","author":"Soliman","year":"1998","journal-title":"Metabolism"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1530\/eje.0.1380394","article-title":"GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with beta-thalassaemia","volume":"138","author":"Soliman","year":"1998","journal-title":"European Journal of Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD012284.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/tropej\/45.1.23","article-title":"Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: A comparative study","volume":"45","author":"Soliman","year":"1999","journal-title":"Journal of Tropical Pediatrics"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.3109\/03630260903347781","article-title":"Growth and factors affecting it in thalassemia major","volume":"33 Suppl 1","author":"Soliman","year":"2009","journal-title":"Hemoglobin"},{"issue":"222","key":"10.1002\/14651858.CD012284.pub2-BIB0061|cit61","first-page":"79","article-title":"Growth hormone deficiency in adults with thalassemia: an overview and the I-CET recommendations","volume":"Sep","author":"Soliman","year":"2013","journal-title":"Georgian Medical News"},{"issue":"2","key":"10.1002\/14651858.CD012284.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4103\/2230-8210.131750","article-title":"Insulin-like growth factor- I and factors affecting it in thalassemia major","volume":"19","author":"Soliman","year":"2015","journal-title":"Indian Journal of Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0063|cit63","unstructured":"Sterne JAC Egger M Moher D editor(s) on behalf of the Cochrane Bias Methods Group Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editor(s). Cochrane Handbook forSystematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012284.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.3109\/03630260903346676","article-title":"Iron overload: consequences, assessment, and monitoring","volume":"33 Suppl 1","author":"Taher","year":"2009","journal-title":"Hemoglobin"},{"issue":"42","key":"10.1002\/14651858.CD012284.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14420","article-title":"Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation","volume":"14","author":"Takeda","year":"2010","journal-title":"Health Technology Assessment"},{"issue":"2","key":"10.1002\/14651858.CD012284.pub2-BIB0066|cit66","first-page":"642","article-title":"Endocrine complications in patients with thalassaemia major","volume":"5","author":"Toumba","year":"2007","journal-title":"Pediatric Endocrinology Reviews"},{"issue":"16","key":"10.1002\/14651858.CD012284.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM199910143411607","article-title":"Growth hormone therapy in adults and children","volume":"341","author":"Vance","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"51","key":"10.1002\/14651858.CD012284.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"51261-6","DOI":"10.1074\/jbc.M309486200","article-title":"Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation","volume":"278","author":"Woelfle","year":"2003","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1002\/14651858.CD012284.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/asheducation-2011.1.443","article-title":"Impact of iron assessment by MRI","volume":"2011","author":"Wood","year":"2011","journal-title":"Hematology. American Society of Hematology. Education Program"},{"issue":"10","key":"10.1002\/14651858.CD012284.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00277-003-0712-3","article-title":"Growth hormone (GH) deficiency in patients with \u03b2-thalassemia major and the efficacy of recombinant GH treatment","volume":"82","author":"Wu","year":"2003","journal-title":"Annals of Hematology"},{"issue":"6","key":"10.1002\/14651858.CD012284.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/dme.12184","article-title":"Influence of glucocorticoids and growth hormone on insulin sensitivity in humans","volume":"30","author":"Yuen","year":"2013","journal-title":"Diabetic Medicine"}],"updated-by":[{"DOI":"10.1002\/14651858.cd012284.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD012284.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T21:04:11Z","timestamp":1719435851000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD012284.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,18]]},"references-count":71,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012284.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,18]]}}}